£113.69

About as cheap as it gets — within 5% of the all-time low it hit 1 month ago.

£114 today · all-time low £113 (Oct 2026) · usually £113

Springer Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 64 days · 64 data points (no recent data)

Historical
Generating forecast…
£113.76 £112.45 £112.74 £113.02 £113.31 £113.59 £113.88 22 August 2026 06 September 2026 22 September 2026 08 October 2026 24 October 2026
View at Amazon ↗

Price data last checked 27 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 64 days • 2 price levels

Days at Price
Current Price
5 days 59 days · current 0 15 30 44 59 £113 £114 Days at Price

Price Analysis

Most common price: £114 (59 days, 92.2%)

Price range: £113 - £114

Price levels: 2 different prices over 64 days

Description

This book examines evolving paradigms in antigen presentation, dendritic cell biology, innate response and immunosuppressive mechanisms and strategies for manipulation of the immune system to treat neuroblastoma, leukemia, melanoma, lung cancer and more. From the Back Cover This volume explores recent advances in understanding of fundamental immunology  and insights into  the dynamic interactions between tumors and the immune system, that  provide new opportunities  for therapeutic  intervention in cancer.  Chapter topics include evolving paradigms in the innate and adaptive response,   newly appreciated immunosuppressive mechanisms,  and  novel preclinical  strategies for manipulation of the immune system for therapeutic benefit in cancer. In addition, recent successes in the clinic, and emerging opportunities are covered. Future possibilities, such as the use of antibody engineering, fusion proteins,  and the retargeting of immune cells through T-cell receptor engineering are discussed by  leaders in the field,  focusing  on recent clinical experience, promising technologies, and challenges to clinical success.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
23 August 2016
Listed Since
22 July 2016

Barcode

No barcode data available

Similar Products You Might Like

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
97% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£112.59 28 Oct 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
90% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£179.97 24 Oct 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
89% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£114.89 23 Oct 2026
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
89% match

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Springer

£148.19 21 Oct 2026
Immunotherapy for Gastrointestinal Cancer
88% match

Immunotherapy for Gastrointestinal Cancer

Springer

£99.11 27 Oct 2026
Innate and Adaptive Immunity in the Tumor Microenvironment: 1
87% match

Innate and Adaptive Immunity in the Tumor Microenvironment: 1

Springer

£75.41 30 Oct 2026
Immunotherapy for Pediatric Malignancies
87% match

Immunotherapy for Pediatric Malignancies

Springer

£113.90 26 Oct 2026
Experimental and Applied Immunotherapy
86% match

Experimental and Applied Immunotherapy

Humana

£140.31 12 Oct 2026
Tumor Immunology (Advances in Immunology): Volume 130
86% match

Tumor Immunology (Advances in Immunology): Volume 130

Elsevier

£117.00 17 Nov 2026
Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy: 9 (Resistance to Targeted Anti-Cancer Therapeutics, 9)
86% match

Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy: 9 (Resistance to Targeted Anti-Cancer Therapeutics, 9)

Springer

£75.14 29 Oct 2026
Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)
86% match

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Humana

£113.76 23 Oct 2026
Experimental and Applied Immunotherapy
86% match

Experimental and Applied Immunotherapy

Humana

£149.98 26 Oct 2026
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
86% match

Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)

Springer

£75.96 24 Oct 2026
Cancer Immunology: 30 (Immunology and Medicine, 30)
85% match

Cancer Immunology: 30 (Immunology and Medicine, 30)

Springer

£113.76 26 Oct 2026
Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)
85% match

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)

Springer

£165.38 25 Oct 2026
Brain Tumor Immunotherapy
85% match

Brain Tumor Immunotherapy

Humana

£128.74 26 Oct 2026
Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy: Part B: Volume 166 (Advances in Immunology, Volume 166)
85% match

Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy: Part B: Volume 166 (Advances in Immunology, Volume 166)

Elsevier

£128.27 24 Oct 2026
Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)
85% match

Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)

Springer

£113.76 22 Oct 2026
NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)
85% match

NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)

Elsevier

£135.97 23 Oct 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
85% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£110.00 23 Oct 2026
Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)
85% match

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Humana

£37.01 28 Oct 2026
Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)
84% match

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Humana

£113.77 30 Oct 2026
Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
84% match

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)

Springer

£108.78 22 Oct 2026
Immuno-Oncology: From Bench to Bedside
84% match

Immuno-Oncology: From Bench to Bedside

CREATESPACE

£82.80 30 Oct 2026